{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:35:23Z","timestamp":1781609723739,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SCA-145103"],"award-info":[{"award-number":["SCA-145103"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015452","name":"Canadian Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.akdh.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T04:23:06Z","timestamp":1702354986000},"page":"407-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the Risk of Progression to Kidney Failure in Patients With Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1053","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-6286","authenticated-orcid":false,"given":"Matthew B.","family":"Lanktree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-1093","authenticated-orcid":false,"given":"York","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Jul 22","key":"10.1053\/j.akdh.2023.06.002_bib1","article-title":"Opportunities and challenges for genetic studies of end-stage renal disease in Canada","volume":"5","author":"Kalatharan","year":"2018","journal-title":"Can J Kidney Health Dis"},{"issue":"10174","key":"10.1053\/j.akdh.2023.06.002_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history","volume":"28","author":"Iliuta","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1681\/ASN.2008040441","article-title":"A clinical view of simple and complex renal cysts","volume":"20","author":"Eknoyan","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12882-020-02084-1","article-title":"Ultrasound to address medullary sponge kidney: a retrospective study","volume":"21","author":"Pisani","year":"2020","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.06.002_bib8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ndt\/gfy261","article-title":"Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease","volume":"34","author":"Lanktree","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2019.04.018","article-title":"Intrafamilial variability of ADPKD","volume":"4","author":"Lanktree","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.06.002_bib11","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing","volume":"23","author":"Rossetti","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.11100720","article-title":"Patients with protein-truncating PKD1 mutations and mild ADPKD","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in Phosphomannomutase 2","volume":"28","author":"Cabezas","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-013-2706-2","article-title":"ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies","volume":"30","author":"Bergmann","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.06.002_bib16","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.2017111200","article-title":"NPHP1 (Nephrocystin-1) gene deletions cause adult-onset ESRD","volume":"29","author":"Snoek","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.06.002_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ekir.2021.11.004","article-title":"Alport syndrome with kidney cysts is Still Alport syndrome","volume":"7","author":"Savige","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ekir.2019.09.004","article-title":"Collagen IV gene mutations in adults with bilateral renal cysts and CKD","volume":"5","author":"Gulati","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.akdh.2023.06.002_bib19","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.akdh.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1053\/j.akdh.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Besse","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","article-title":"Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype","volume":"109","author":"Senum","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1053\/j.akdh.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ajhg.2022.06.013","article-title":"Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis","volume":"109","author":"Lemoine","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.akdh.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into autosomal dominant polycystic kidney disease from genetic studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.kint.2019.11.019","article-title":"Next-generation sequencing for detection of somatic mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Devuyst","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2019.08.038","article-title":"Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Hopp","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.akdh.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2021050690","article-title":"Detection of PKD1 and PKD2 somatic variants in autosomal dominant polycystic kidney cyst epithelial cells by whole-genome sequencing","volume":"32","author":"Zhang","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2014101051","article-title":"Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease","volume":"27","author":"Audr\u00e9zet","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2215\/CJN.07830520","article-title":"Risk factors for CKD progression: overview of findings from the CRIC study","volume":"16","author":"Hannan","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.kint.2021.01.028","article-title":"The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC\/RC mouse model of autosomal dominant polycystic kidney disease","volume":"99","author":"Arroyo","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","article-title":"Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions","volume":"11","author":"Fahed","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1053\/j.akdh.2023.06.002_bib33","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s00125-021-05491-7","article-title":"Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control","volume":"64","author":"Tremblay","year":"2021","journal-title":"Diabetologia"},{"key":"10.1053\/j.akdh.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","article-title":"Genome-wide polygenic score to predict chronic kidney disease across ancestries","volume":"28","author":"Khan","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.xkme.2021.03.004","article-title":"Pain and obesity in autosomal dominant polycystic kidney disease: a Post Hoc analysis of the Halt progression of polycystic kidney disease (HALT-PKD) studies","volume":"3","author":"Nowak","year":"2021","journal-title":"Kidney Med"},{"issue":"7","key":"10.1053\/j.akdh.2023.06.002_bib37","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1093\/ndt\/gfr744","article-title":"The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease","volume":"27","author":"Reed","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2023.06.002_bib38","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan Gopala","year":"2022","journal-title":"NEJM Evidence"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","article-title":"Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease","volume":"98","author":"Kramers","year":"2020","journal-title":"Kidney Int"},{"issue":"20","key":"10.1053\/j.akdh.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in Later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1053\/j.akdh.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1038\/s41598-022-24104-w","article-title":"Atypical polycystic kidney disease by imaging","volume":"13","author":"Iliuta","year":"2023","journal-title":"Sci Rep"},{"issue":"20","key":"10.1053\/j.akdh.2023.06.002_bib44","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02927815","article-title":"Volume of polycystic kidneys during reduction of renal function","volume":"3","author":"Thomsen","year":"1981","journal-title":"Urol Radiol"},{"issue":"7","key":"10.1053\/j.akdh.2023.06.002_bib46","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s00261-022-03521-5","article-title":"Automated measurement of total kidney volume from 3D ultrasound images of patients affected by polycystic kidney disease and comparison to MR measurements","volume":"47","author":"Jagtap","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41598-017-01779-0","article-title":"Automatic segmentation of kidneys using deep learning for total kidney volume quantification in autosomal dominant polycystic kidney disease","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10278-017-9978-1","article-title":"Performance of an artificial multi-observer deep neural network for fully automated segmentation of polycystic kidneys","volume":"30","author":"Kline","year":"2017","journal-title":"J Digit Imaging"},{"issue":"8","key":"10.1053\/j.akdh.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1681\/ASN.2018090902","article-title":"Automatic measurement of kidney and liver volumes from MR images of patients affected by autosomal dominant polycystic kidney disease","volume":"30","author":"van Gastel","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib50","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00261-020-02748-4","article-title":"Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease","volume":"46","author":"Kline","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10278-021-00452-3","article-title":"Semantic instance segmentation of kidney cysts in MR images: a Fully automated 3D approach developed through active Learning","volume":"34","author":"Gregory","year":"2021","journal-title":"J. Digit. Imaging"},{"issue":"3","key":"10.1053\/j.akdh.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00261-017-1236-y","article-title":"Quantitative MRI of kidneys in renal disease","volume":"43","author":"Kline","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1053\/j.akdh.2023.06.002_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RLI.0000000000000633","article-title":"Magnetic resonance kidney Parenchyma-T2 as a Novel imaging biomarker for autosomal dominant polycystic kidney disease","volume":"55","author":"Siedek","year":"2020","journal-title":"Invest Radiol"},{"issue":"1","key":"10.1053\/j.akdh.2023.06.002_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12882-016-0381-9","article-title":"Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study","volume":"17","author":"Suwabe","year":"2016","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.06.002_bib55","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.kint.2017.03.026","article-title":"Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease","volume":"92","author":"Kline","year":"2017","journal-title":"Kidney Int"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:39:49Z","timestamp":1757432389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2949813923000599"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.06.002","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the Risk of Progression to Kidney Failure in Patients With Autosomal Dominant Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}